7/29/2019 Pioderma 2013 http://slidepdf.com/reader/full/pioderma-2013 1/53 Pioderma Dr. M. Izazi HP, SpKK Departemen Ilmu Kesehatan Kulit dan Kelamin Fakultas Kedokteran UNSRI/RSMH Palembang
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 1/53
Pioderma
Dr. M. Izazi HP, SpKK
Departemen Ilmu Kesehatan Kulit dan
Kelamin Fakultas Kedokteran UNSRI/RSMHPalembang
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 2/53
Pyodermas are infections in the epidermis, just below the
stratum corneum or in hair follicles.
Primarily caused by Staphylococcus aureus and group Astreptococcus.
cause a broad clinical spectrum of infection :
superficial pyodermas to invasive soft tissue infectionsdepending on : the organism
the anatomic location of infections
host factors
Pyodermas
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 3/53
S. aureus permanently colonizes the anterior nares in 20 % of thepopulation.
Other sites of colonization : the axillae, perineum, pharynx, and hands.
Contributing factors: Immunosuppression, atopic dermatitis, pre-existingtissue injury, and inflammation.
Treatment: : change predisposing conditions, if possible
topical, oral, or parenteral antibioticsconsider local and current antimicrobial resistance patterns
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 4/53
A. NON-BULLOUS IMPETIGO
Etiology :- Industrialized nations : most commonly caused by S. aureus
- developing nations : common cause by Group A streptococcus
> 70 % of pyoderma. Occurs in children & in adults.
Pathogenesis.
- Intact skin is usually resistant to colonization or impetiginization, possiblydue to absence of fibronectin receptors for teichoic acid moieties onS. aureus & group A streptococcus.
- In a typical sequence, S. aureus spreads from nose to normal skin
(approximately 11 days later) and then develop into skin lesions (after another 11 days).
- Conditions that disrupt the integrity epidermis a portal of entry include : insect bites, epidermal dermatophytoses, herpes simplex,
varicella, abrasions, lacerations, and thermal burns.
Impetigo
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 5/53
Cutaneous Lesions
- Lesions commonly arise on the skin of the face(especially around the nares) or extremities after trauma
- Constitutional symptoms are absent
- The initial lesion is a transient vesicle or pustule that quickly evolvesinto a honey-colored crusted plaque (Ø can enlarge to > 2 cm)
- Surrounding erythema may be present
- Regional lymphadenopathy may be present > 90 % of patientswith prolonged, untreated infection
- Untreated, the lesions may slowly enlarge and involve new sites over several weeks
- In some individuals, lesions resolve spontaneously. In others, thelesions extend into the dermis, forming an ulcer (Ecthyma)
Differential Diagnosis :
Seborrheic dermatitis, Atopic dermatitis, Allergic contact dermatitis,
Epidermal dermatophyte infections, Tinea capitis, Herpes simplex,
Varicella, Herpes zoster, Scabies, Pediculosis capitis
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 6/53
FIGURE . Staphylococcus aureus: Impetigo. Erythema and crusting on thenose (A), which can spread to involve the entire centrofacialregion (B).
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 7/53
B. BULLOUS IMPETIGO
Three types of skin eruptions can be produced by phagegroup II S. aureus, particularly strains 77 and 55:
(1) bullous impetigo
(2) exfoliative disease (SSSS)
(3) nonstreptococcal scarlatiniform eruption
(staphylococcal scarlet fever)
All three represent varying cutaneous responses to
extracellular exfoliative toxins ("exfoliatin") types A and B
produced by these staphylococci
Exfoliative toxin A acts as a serine protease of
desmoglein 1, the desmosomal cadherin
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 8/53
Cutaneous Lesions
commonly in newborn and older infants
characterized by : rapid progression of vesicles to flaccid bullae Bullae usually arise on areas of grossly normal skin
The Nikolsky sign (sheet-like removal of epidermis by shearingpressure) is not present
Bullae initially contain clear yellow fluid that subsequently becomesdark yellow and turbid, and their margins are sharply demarcated
without an erythematous halo The bullae are superficial 1-2 days rupture & collapse
thin, light-brown to golden-yellow crusts
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 9/53
Laboratory Tests
- Gram stain of exudates : Gram-positive cocci in clusters
- culture from the contents of intact bullae : S. aureus phage group II
Histologically
- vesicle formation in the subcorneal or granular region
- occasional acantholytic cells within the blister
- spongiosis
- edema of the papillary dermis
- a mixed infiltrate of lymphocytes and neutrophils around blood
vessels of the superficial plexus
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 10/53
Differential Diagnosis :
Contact dermatitis, Bullous insect bites, Bullous tinea,
Bullous fixed drug reaction, Bullous drug eruption, SSS,Thermal burns, Pemphigus vulgaris, Bullous pemphigoid,Erythema multiforme, Dermatitis herpetiformis, herpes simplex,Varicella.
Prognosis and clinical course
- Untreated, invasive infection can complicate :
cellulitis, lymphangitis, and bacteremia, osteomyelitis, septic arthritis,pneumonitis, and septicemia.
- Exfoliatin production can lead to :
SSSS in infants and in adults immunocompromised or impaired renal function
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 11/53
Treatment
mild to moderate cases : mupirocin ointment or cream, removal of crusts,
and good hygiene
Extensive cases systemic antibiotics :
- dicloxacillin (or similar penicillinase-resistant semi-syntheticpenicillin), 250 - 500 mg, PO qid, or
- erythromycin (in penicillin-allergic patient), 250 - 500 mg, PO qid
Treatment for 5 to 7 days (10 days if streptococci are isolated).
- azithromycin, PO (in adults 500 mg on the first day, 250 mg dailyon the next 4 days).
- amoxicillin plus clavulanic acid, 25 mg/ kg/day, tid [erythromycin-resistant S. aureus, commonly impetigo lesions of children]
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 12/53
FIGURE . Bullous impetigo in a child.
Note blisters filled with cloudy fluid and lesions that
have ruptured, leading to erosions and crusting
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 13/53
Treatments for Impetigo
T0PICAL SYSTEMIC
First line Mupirocin bid Dicloxacillin 250-500 mg PO qid for 5-7 days
Fusidic acid bid Amoxicillin plus clavu 25 mg/kg tid; 250-500 mg qidlanic acid; cephalexin
Second Azithromycin 500 mg x 1, then 250 mg daily for 4 days
line
(penicillin Clindamycin 15 mg/kg/day tid
allergy) Erythromycin 250-500 mg PO qid for 5-7 days
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 14/53
Ecthyma Ecthyma is a cutaneous pyoderma characterized by thickly crusted erosions
or ulcerations
Lesion can evolve from a primary pyoderma or within a preexistingdermatosis or site of trauma.
usually a consequence of neglected impetigo and classically evolves inimpetigo occluded by footwear and clothing.
S. aureus and/or group A streptococcus can be isolated on culture.
Untreated staphylococcal or streptococcal impetigo can extend moredeeply, penetrating the epidermis, producing a shallow crusted ulcer
Ecthyma occurs most commonly on the lower extremities of children, or neglected elderly patients, or individuals with diabetes.
Poor hygiene and neglect are key elements in pathogenesis.
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 15/53
The ulcer has :
- a "punched out" appearance when the dirty grayish-yellowcrust and purulent material are debrided.
- The margin of the ulcer is indurated, raised, and violaceous,and the granulating base extends deeply into the dermis.
Untreated ecthymatous lesions enlarge over weeks to months to adiameter of 2 to 3 cm or more.
The lesions are slow to heal, requiring several weeks of antibiotictreatment for resolution.
The complications :
- spread by autoinoculation or by insect vectors
- post-streptococcal sequela (glomerulonephritis)
Management of ecthyma is the same as for staphylococcal impetigo
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 16/53
FIGURE Ecthyma. Multiple thicklycrusted ulcers on the leg
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 17/53
Folliculitis
Folliculitis is a pyoderma that begins within the hair follicle
classified according : depth of invasion (superficial & deep), & microbialetiology
SUPERFICIAL FOLLICULITIS
Superficial folliculitis or follicular / Bockhart impetigo
- A small, fragile, dome-shaped pustule occurs at the infundibulum (ostiumor opening) of a hair follicle, often on the scalps of children and in thebeard area, axillae, extremities, and buttocks of adults
- cause by S. aureus
Periporitis staphylogenes refers to secondary infection of miliaria of theneonate by S. aureus.
Staphylococcal blepharitis is an S. aureus infection of the eyelids, presentingwith scaling or crusting of the eyelid margins, often with associatedconjunctivitis. The differential diagnosis includes seborrheic dermatitis androsacea of the eyelid.
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 18/53
S. aureus folliculitis must be differentiated from :
- Three non-infectious, inflammatory, follicular disorders are morecommon in black men : S. aureus can cause secondary infection
+ pseudofolliculitis barbae, which occurs on the lower beard area;
+ folliculitis keloidalis or acne keloidalis nuchae, on the nape of the neck
+ perifolliculitis capitis, on the scalp
- Irritant folliculitis : exposure to mineral oils, tar products, & cutting oils
- Acne vulgaris
- drug-induced acneform eruptions- rosacea
- hidradenitis suppurativa
- acne necrotica of the scalp, and
- eosinophilic folliculitis of HIV disease
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 19/53
DEEP FOLLICULITIS
Sycosis barbae : a deep folliculitis with perifollicular inflammation
in the bearded areas of the face and upper lip- If untreated : lesions may become more deeply seated and chronic
- treatment : with warm saline compresses and local antibiotics
(mupirocin or topical clindamycin) may be sufficient to
control infection.
More extensive cases require systemic antibiotic therapy
Lupoid sycosis : a deep, chronic form of sycosis barbae associated
with scarring, usually occurring as a circinate lesion
- A central cicatrix surrounded by pustules and papules gives theappearance of lupus vulgaris
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 20/53
20
Figure 4. Bacterial folliculitis. A pustule pierced by a hair.
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 21/53
Furuncles and Carbuncles
A furuncle or boil is a deep-seated inflammatory
nodule that develops around a hair follicle,
usually from a preceding, more superficial
folliculitis and often evolving into an abscess.
A carbuncle is a more extensive, deeper,
communicating, infiltrated lesion that develops
when suppuration occurs in thick inelastic skin
when multiple, closely set furuncles coalesce.
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 22/53
FURUNCLES
- Furuncles arise in hair-bearing sites, particularly in regions subject tofriction, occlusion, and perspiration, such as the neck, face, axillae, and
buttocks.
- They may complicate pre-existing lesions such as atopic dermatitis,excoriations, abrasions, scabies, or pediculosis, but occur more often inthe absence of any local predisposing causes.
- systemic host factors is associated with furunculosis :obesity, blood dyscrasias, defects in neutrophil function(defects in chemotaxis associated with eczema and high levels of IgE,defects in intracellular killing of organisms as in chronic granulomatousdisease of childhood), treatment with glucocorticoids and cytotoxicagents, and immunoglobulin deficiency states.
- The process is often more extensive in patients with diabetes. Themajority of patients with problems of furunculosis appear to beotherwise healthy
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 23/53
Cutaneous Lesions
- A furuncle starts as hard, tender, red folliculocentric nodule in hair-bearing skin that enlarges and becomes painful and fluctuant
after several days (i.e., undergoes abscess formation).
- Rupture occurs, with discharge of pus and often a core of necroticmaterial. The pain surrounding the lesion then subsides, and theredness and edema diminish over several days to several weeks.
- Furuncles may occur as solitary lesions or as multiple lesions insites such as the buttocks
Differential Diagnosis :
- Cystic acne
- Kerion- Hidradenitis suppurativa
- Ruptured epidermal inclusion cyst Furuncular myiasis
- Apical dental abscess
- Osteomyelitis
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 24/53
Figure 24.10 A
furuncle or aboil begins as a
tender, inflamed
nodule that
usually
becomes
fluctuant,points, and
ruptures.
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 25/53
CARBUNCLES
A carbuncle is a larger, more serious inflammatory lesion with a
deeper base, characteristically occurring as an extremely painfullesion at the nape of the neck, the back, or thighs
Fever and malaise are often present, and the patient may appear quite ill.
The involved area is red and indurated, and multiple pustules soonappear on the surface, draining externally around multiple hair follicles.
The lesion soon develops a yellow-gray irregular crater at thecenter, which may then heal slowly by granulating, although the area
may remain deeply violaceous for a prolonged period.
The resulting permanent scar is often dense and readily evident.
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 26/53
LABORATORY TESTS
Extensive furunculosis or a carbuncle may be associated with leukocytosis.
S. aureus is almost always the cause.
Histologic examination
furuncle shows a dense polymorphonuclear inflammatory process in the
dermis and subcutaneous fat
In carbuncles, multiple abscesses, separated by connective-tissue
trabeculae, infiltrate the dermis and pass along the edges of the hair
follicles, reaching the surface through openings in the undermined
epidermis.
The diagnosis is made on the basis of the clinical appearance.Confirms the diagnosis :
- Gram stain of pus : clusters of Gram-positive cocci
- Culture : isolation of S. aureus
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 27/53
PROGNOSIS AND CLINICAL COURSE
The major problems with furunculosis and carbuncles are
bacteremic spread of infection and recurrence.
Lesions about the lips and nose raise the specter of spread via thefacial and angular emissary veins to the cavernous sinus.
Invasion of the bloodstream may occur from furuncles or carbunclesat any time, in an unpredictable fashion, resulting in metastaticinfection such as osteomyelitis, acute endocarditis, or brain abscess
Recurrent furunculosis is a troublesome process that may continue
for many years.
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 28/53
TREATMENT
Simple furunculosis may be aided by local application of moist heat.
A carbuncle or a furuncle with surrounding cellulitis, or one withassociated fever, should be treated with a systemic antibiotic (as for impetigo)
- For severe infections or infections in a dangerous area, maximalantibiotic dosage should be employed by the parenteral route
. - If MRSA is implicated or suspected in serious infections :vancomycin (1.0 to 2.0 g intravenously daily in divided doses)
Antibiotic treatment should be continued for at least 1 week
- incision and drainage, when the lesions are large, painful, and
fluctuant
- draining lesions should be covered to prevent autoinoculation anddiligent hand washing performed
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 29/53
Figure 24.11
Carbuncle on the
nape of a diabetic
man. This is a
staphylococcal
infection of several
contiguous hair
follicles.
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 30/53
Abscess
Abscesses caused by S. aureus commonly occur in folliculocentric
infections : folliculitis, furuncles, and carbuncles.
Abscesses can also occur at sites of trauma, foreign bodies, burns,or sites of insertion of intravenous catheters.
The initial lesion is an erythematous nodule. If untreated, the lesionoften enlarges, with the formation of a pus-filled cavity
The initial and most important treatment of an abscess is incisionand drainage and antibiotic treatment as for furuncles
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 31/53
31
FIGURE 7. Staphylococcus aureus abscess. A large painful abscess
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 32/53
Erysipelas
Synonyms : st. anthony’s fire & ignis sacer
Erysipelas Is an acute beta-hemolytic group A streptococcal infection
of the skin involving the superficial dermal lymphatics
Cause by group A - hemolytic streptococcus (very uncommonly groupC or G streptococcus) and rarely caused by S. aureus
Group B – streptococcus is often responsible in newborn and may be
the cause of abdominal or perineal erysipelas in postpartum women
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 33/53
Clinical features
- most frequent sites affected : face & legs
- prodromal symptoms : malaise, chills, high fever, headache, vomiting,& joint pains
- skin lesion may vary from transient hyperemia followed by slightdesquamation to intense inflammation with vesiculation & plegmon
- early stage : affected skin is scarlet, hot to the touch, brawny, swolleneruption begins as an erythematous patch & spreads by peripheralextension
A distinctive feature of the inflammation is advancing edge of the wallto the palpating finger (highly characteristic raised, indurated border)
- In some cases vesicles or bullae contain seropurulent fluid & mayresult in local gangrene
- Commonly with a polymorphonuclear leukocytosis of ≥ 20.000 / mm³
- Many cases : solely as an erythematous lesion without systemic
complaints
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 34/53
Complications :
septicemia or deep cellulitis, more common in newborn & followingoperations on the elderly
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 35/53
Predisposing causes :
- operative wounds
- fissures in the nares, auditory meatus, under the lobes of theears, anus or penis, & between or under the toes
- Any inflammation of the skin, especially is fissured or ulcerative,- abrasions or scratches, accidental scalp wounds, vaccination, &chronic leg ulcers
Differential Diagnosis :
- contact dermatitis from plans, drugs, or dyes
- angioneurotic edema
- scarlet fever : widespread punctate erythema, never localized &edematous as erysipelas
- A butterfly pattern on the face may mimic lupus erythematosus
- ear involvement may suggest relapsing polychondritis- Acute tuberculoid leprosy of the face may look like erysipelasbut the absence of fever, pain, or leukocytosis
fever, pain, &
tenderness are
absent & itching issevere
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 36/53
Treatment
- Locally, ice bags & cold compresses may be used
- Systemic penicillin is rapidly effective. Improvement in the general
condition occurs in 24 to 48 hours, but resolution of the cutaneouslesion may require several days
- treatment with antibiotics should be continued for at least 10 days -
- Erythromycin is also efficacious
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 37/53
37
FIGURE 8. Erysipelas. There is painful, warm erythema of the
lower extremity with well defined borders.
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 38/53
Cellulitis
Cellulitis is an infection of the deep dermis & subcutaneous tissue
caused most commonly by str.pyogenes & S. aureus.
Predisposition factor : lymphedema, alcoholism, DM, IV drug abuse, &
peripheral vascular disease.
Pathogenesis
- bacteria may gain access to the dermis via an external / a break inthe skin barrier (immunocompetent patient) or a hematogenous
route (immunocompromised patient)
- recurrent bouts of cellulitis may be caused by damage to the
lymphatic system (e.g. previous lymph node dissection, prior
episode of acute cellulitis
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 39/53
Clinical features
- most common location : head & neck (children), extremities (adults)
- often preceded by systemic symptoms : fever, chills & malaise
- affected area : erythrma, warmth, pain, & swelling.
- the lesion usually has ill defined, non palpable borders. In severe
infections may occur : vesicles, bullae, pustules or necrotic tissue.
- the erythema rapidly become intense & spreads. The area become
infiltrated & pits on pressure. Sometimes the central part become
nodular & surmounted by a vesicle that ruptures & discharges pus &
necrotic material. Streaks of Lymphangitis may spread from the area
to the neighboring lymph glands.
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 40/53
- complication (rare) : acute glomerulonephritis, lymphadenitis, &subacute bacterial endocarditis
recurrent cellulitis (damage to lymphatic vessel)
gangrene, abscesses, & sepsis
Pathology
- in dermis : infiltrate lymphocytes & neutrophils
edema & dilation of lymphatics & small blood vessels
in severe dermal edema may be seen subepidermal bullae
Laboratory examination
- diagnosis cellulitis usually clinical
- the leukocyte count is usually normal / slightly elevated
- culture & sensitivities should be obtained, if sign & symptom do notimprove after 24 – 36 hours of treatment : the primary site of infection,aspiration of the advancing edge, skin biopsy, or blood culture
- blood culture are almost always negative in immunocompetent host
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 41/53
Treatment
- immobilization & elevation of the area affected
- application of wet dressing to area with bullae or exudate
- treatment should be targeted against Str.pyogenes & S.aureus- mild cases require a 10 days course of an oral antibiotic
- hospitalization & parenteral antibiotic : fasial cellulitis or seriously ill
(Intravenous penicillinase-resistant penicillins or first generation
cephalosporin are usually effective)
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 42/53
FIGURE A. Cellulitis. The lower
extremity is swollen, erythematous, and
tender; there is blistering and crusting.
FIGURE B. Cellulitis after puncture trauma. The
forearm is swollen, erythematous, and tender;
there is abscess formation, blistering, and
crusting.
FIGURE C. Cellulitis arising at the site
of a surgical excision: Staphylococcusaureus. Note discharge of pus.
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 43/53
Staphylococcal Scalded-Skin Syndrome (SSSS)
Synonyms : Ritter’s disease, pemphigus neonatorum
SSSS is a toxin-mediated epidermolytic disease characterized byerythema and widespread detachment of the superficial layers of theepidermis, resembling scalding
Onset : most common in neonates during first 3 months of lifeInfants and young children <5 years. Rare in adults
Etiology : S. aureus of phage group 2 (types 71 and 55), whichproduces exfoliative toxins A and B (ET-A and ET-B). Site of ET
production: purulent conjunctivitis, otitis media omphalitis, occultnasopharyngeal infection; bullous impetigo
Risk Factors : age <5 yearsadults: renal failure, systemic immunosuppression
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 44/53
Pathogenesis
In newborns and infants, S. aureus colonizes nose, conjunctivae, or
umbilical stump with or without causing clinically apparent infection,producing ETs that are transported hematogenously to the skin
In bullous impetigo, ET is produced in impetigo lesion
Specific antistaphylococcal antibody, metabolic differences, or thegreater ability to localize, metabolize, and excrete in individuals >5 years
probably accounts for decreased incidence of SSSS with older age ET causes acantholysis and intraepidermal cleavage within the stratum
granulosum
More extensive epidermal damage is characterized by sloughing of superficial epidermis in SSSS
Healing occurs spontaneously in 5 to 7 days
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 45/53
Clinical features
Localized Form (Bullous Impetigo)
- Intact flaccid purulent bullae, clustered. Rupture of the bullae results inmoist red and/or crusted erosive lesions. Lesions are often clustered in anintertriginous area
Generalized Form
- ET-induced changes : micromacular scarlatiniform rash or diffuse, ill-defined erythema and a fine, sandpaper appearance occur initially
- In 24 h, erythema deepens in color and involved skin becomes tender.Initially periorificially on face, neck, axillae, groins; becoming more widespreadin 24 to 48 h. Initial erythema and later sloughing of superficial layers of epidermis are most pronounced periorificially on face and in flexural areas onneck, axillae, groins, antecubital area, back (pressure points)
- With epidermolysis, epidermis appears wrinkled and can be removed bygentle pressure (skin resembles wet tissue paper) (Nikolsky's sign)
- In some infants, flaccid bullae occur. Unroofed epidermis forms erosionswith red, moist base. Desquamation occurs with healing
Mucous Membranes : Uninvolved
General Examination : possible low-grade fever, Irritable child & pain
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 46/53
Differential Diagnosis : drug-induced TEN, Kawasaki's syndrome
Laboratory Examinations
- Gram's Stain : gram-positive cocci only at colonized site, not in
areas of epidermolysis- Bacterial Culture : S. aureus only at site of infection (i.e., site of
toxin production)—umbilical stump, ala nasi, nasopharynx,conjunctivae, external ear canal, stool. S. aureus is not recoveredfrom sites of sloughing skin or bullae
- Dermatopathology : Intraepidermal cleavage with splitting
occurring beneath and within stratum granulosum Diagnosis
Clinical findings confirmed by bacterial cultures
Course and Prognosis
Adequate antibiotic treatment : the superficially denuded areas heal in3 to 5 days associated with generalized desquamation in large sheetsof skin; there is no scarring.
Death can occur in neonates with extensive disease
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 47/53
Management
Prophylaxis : prevent spread of toxigenic S. aureus in neonatal careunits
General Care- Hospitalization is recommended for neonates and young children,
especially if skin sloughing is extensive and parental compliancequestionable.
- Discharge home when significant improvement is apparent. If case ismild and home care reliable, children can be treated with oral antibiotic
Topical Therapy
- Baths or compresses for debridement of necrotic superficial epidermis.- Topical antimicrobial agents for impetigo lesions: mupirocin ointment,
bacitracin, or silver sulfadiazine ointment
Systemic Antimicrobial Therapy : See Table 1
Adjunctive Therapy
- Replace significant water and electrolyte loss intravenously in severecases
Antimicrobial agent Dosing
U ll f 7 14 dTable 1. Oral
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 48/53
Usually for 7 – 14 days
Natural penicillin
Penicillin V
Penicillin G
Benzathine Penicillin G
250-500 mg tid/qid for 10 days
600.000 – 1,2 million U IM qd for 7 days
600.000 U IM for ≤ 6 years
1,2 million U IM for ≥ 7 years
Penicillinase- resistant penicillins
Cloxacillin
Dicloxacillin
NafcillinOxacillin
250 – 500 mg (adult) qid for 10 days
250 – 500 mg (adult) qid for 10 days
1.0-2.0 g IV q4h
1.0-2.0 g IV q4h
Aminopenicillins
Amoxicillin
Amoxicillin + clavulanic acid
Ampicillin
500 mg tid or 875 mg q12h
875/125 mg bid; 20 mg/kg per day tid for 10 days
250 – 500 mg (adult) qid for 7-10 days
Cephalosporins
Cephalexin
Cephradine
Cefaclor
Cefproxil
Cefuroxime axetil
Cefixime
250 – 500 mg (adult) qid for 10 days;
40-50 mg/kg per day (children) for 10 days
250 – 500 mg (adult) qid for 10 days;
40-50 mg/kg per day (children) for 10 days
250 – 500 mg q8h250 – 500 mg q12h
250 – 500 mg q12h
250 – 500 mg q12-24h
Erythromycin group
Erythromycin ethylsuccinate
Clarithromycin
Azithromycin
250 – 500 mg (adult) qid for 10 days;
40 mg/kg per day (children) for 10 days
500 mg bid for 10 days
500 mg on day 1, then 250 mg qd days 2 -5
Clindamycin 150 – 300 mg (adult) qid for 10 days ;
15 mg/kg per day (children) qid for 10 days
Tetracyclines
Minocycline
Doxycycline
Tetracycline
100 mg bid for 10 days
100 mg bid
250 – 500 mg qid
Miscellaneous agents
Trimethoprim-sulfamethoxazole
Metronidazole
Ciprofloxacin
160 mg TMP + 800 mg SMX bid
500 mg qid
500 mg bid for 7 days
Adapted from Wolff K, Johnson RA, Suurmond D. In. Fitzpatrick’s Color Atlas & Synopsis of Clinical Dermatology. New York:Mc Graw Hill, 2005;p598.
antimicrobial Agents for
Bacterial Infections
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 49/53
Late stage of staphylococcal
scalded-skin syndrome
Generalized desquamation
with large sheets
Pictures of SSSS .
(A) erythema, more superficial blisters with
desquamation of large sheets.
B. Superficial erosions around the eye withunderlying denuded skin.
C. Characteristic crusting with superficial
erosions noted on face of this 10- month-old child
with SSSS.
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 50/53
References
1. Craft N, Lee PK, Zipoli MT, Weinberg AN, Swartz MN, Johnson RA.
Superficial Cutaneous Infections and Pyodermas. In. Freedberg IM,
Eisen AZ, Wolff K, et al: eds. Fitzpatrick’s Dermatology in generalmedicine. 7th ed. New York : Mc Graw-Hill Book Co, 2008: 1649-709.
2. Wolff K, Johnson RA, Suurmond D. In. Fitzpatrick’s Color Atlas &
Synopsis of Clinical Dermatology. New York:Mc Graw Hill, 2005;p598
3. Halpern AV, Heymann WR. Bacterial diseases. In. Bolognia JL,Jorizzo JL, Rapini RP, eds. Dermatology. 2nd ed. New York : Mosby
elsevier, 2008 :p. 1075-106
4. Odom RB , James WD, Berger TG. Andrews’ diseases of the skin. 9th
ed. Philadelphia : WB. Saunders Co, 2000
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 51/53
Classification of Infectious Folliculitis
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 52/53
Classification of Infectious Folliculitis
Bacterial folliculitis
· Staphylococcus aureusfolliculitis
· Periporitis staphylogenes
· Superficial (follicular or Bockhart impetigo)
· Deep (sycosis) [may progress to
furuncle (boil) or carbuncle]
· Pseudomonas aeruginosa folliculitis ("hot tub" folliculitis)
· Gram-negative folliculitis (occurs at the site of acne vulgaris, usually the
face, with long-term antibiotic therapy)
· Syphilitic folliculitis (secondary; acneform) Fungal folliculitis
· Dermatophytic folliculitis
· Tinea capitis
· Tinea barbae
· Majocchi granuloma
· Pityrosporum folliculitis · Candida folliculitis
Viral folliculitis
· Herpes simplex virus folliculitis
· Follicular molluscum contagiosum
Infestation
· Demodicidosis
Table 2 Organisms Antimicrobial Agents of Choice and Alternatives
7/29/2019 Pioderma 2013
http://slidepdf.com/reader/full/pioderma-2013 53/53
Table 2. Organisms, Antimicrobial Agents of Choice, and Alternatives
Infecting Organism Antimicrobial Agent(s) of First Choice Alternative Antimicrobial Agents
Staphylococcus
aureus or epidermidis
Non-penicillinase producing Penicillin G or V A cephalosporin; clindamycin; vancomycin; imipenem;
a f luoroquinolone
Penicillinase-producing A penicillinase-resistant penicillin. PO: dicloxacillin,
cloxacillin. IV for severe infections; nafcillin, oxacillin
A cephalosporin; vancomycin;
amoxicillin/clavulanicacid; ticarcillin/clavulanic acid;
piperacillin/tazobactam; ampicillin/sulbactam;
imipenem; clindamycin; a fluoroquinolone
Methicillin-resistant Vancomycin ± gentamicin ± rifampin Trimethoprim-sulfamethoxazole; a fluoroquinolone;
minocycline; linezolid; quinupristin/dalfopristin
Streptococcu s pyogenes (group
A) and groups C and G
Penicillin G or V An erythromycin, clarithromycin, azithromycin; a
cephalosporin; vancomycin; clindamycin
Streptococcu s, group B Penicillin G or ampicillin A cephalosporin, vancomycin, an erythromycin
Streptococcu s pneumoniae
(pneumococcus)
Penicillin G or V A cephalosporin erythromycin; azithromycin;
clarithromycin; a fluoroquinolone; meropenem;
imipenem; trimethoprim-sulfameth-oxazole;clindamycin; a tetracycline
Penicillin-susceptible (MIC
<0.1 g/mL)
Penicillin G IV (12 million U/d for adults) or ceftriaxone
or cefotaxime
Levofloxacin; vancomycin; clindamycin
Penicillin-intermediate resistance
Penicillin-high level resistance
(MIC 2 g/mL)
Meningitis:
vancomycin + ceftriaxone or cefotaxime ± rifampin
Meropenem; imipenem; clindamycin